Ugspas M 80mg/250mg Tablet
Marketer
Euphony Healthcare
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Ugspas M 80mg/250mg Tablet
Azium Compound 80mg/250mg tablets offer relief from abdominal pain. This dual-action formulation eases bloating, cramping, and discomfort by relaxing gastrointestinal muscles and inhibiting pain-inducing neurotransmitters. Dosage and duration are determined by your physician, based on individual response and condition. Complete the prescribed course; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your doctor of all other medications you're using, as interactions are possible. Common, typically transient side effects include nausea, vomiting, diarrhea, stomach ache, dry mouth, appetite loss, thirst, and heartburn. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until their impact is known. Alcohol consumption should be avoided due to increased dizziness risk. Consult your physician before use if pregnant, planning pregnancy, breastfeeding, or if you have liver or kidney issues; appropriate dosage adjustments may be necessary.
Primary Ingredients of Ugspas M 80mg/250mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Ugspas M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Ugspas M 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Ugspas M 80mg/250mg Tablet should be swallowed whole; do not crush, chew, or break it. Administer this medication with food.
Common Side effects of Ugspas M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Ugspas M 80mg/250mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Ugspas M 80mg/250mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with food.
How Ugspas M 80mg/250mg Tablet works:
Combiflam-M 80mg/250mg tablets combine drotaverine and mefenamic acid to alleviate abdominal discomfort and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms, reducing painful contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of substances triggering abdominal pain and inflammation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ugspas M 80mg/250mg Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Ugspas M 80mg/250mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks prior to prescribing this medication. Seek medical advice before using this drug.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Ugspas M 80mg/250mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Ugspas M 80mg/250mg Tablets, a potential side effect of this medication due to the risk of dizziness.
KidneyCAUTION
Patients with kidney impairment should use Ugspas M 80mg/250mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Ugspas M 80mg/250mg tablets are unsuitable for individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Ugspas M 80mg/250mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Ugspas M 80mg/250mg Tablet :
Should you forget to take your Ugspas M 80mg/250mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ugspas M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
3,018 People bought this recently